Sepsis Diagnostics Market Analysis

Sepsis Diagnostics Market Analysis

To get key market trends

  Download Free Sample

Based on product, the sepsis diagnostics market is bifurcated into instruments, assay kits & reagents, blood culture media, and software. Blood culture media is anticipated to account for a significant revenue approximately 224 million in 2022. Blood culture media are generally less expensive compared to other types of sepsis diagnostics. Moreover, they are more convenient due to their high availability in the market. Additionally, the growing utilization of blood culture media by hospitals & pathology labs contributes to accelerating the market growth.

Based on technology, the sepsis diagnostics market is bifurcated into microbiology, molecular diagnostics, immunoassays, and flow cytometry. Microbiology segment held the highest CAGR at 7.8% during the forecast period. Due to the low cost of microbiology technology and accurate detection & identification of microorganisms for sepsis, microbiology has dominated the market. Moreover, extensive use of blood culture methods for the diagnosis of sepsis will considerably increase the adoption of microbiology.
 

The sepsis diagnostics market is bifurcated based on the method type including conventional diagnostics and automated diagnostics. Conventional diagnostics held a significant revenue around 339 million and is estimated to grow approximately 697 million by 2032. Conventional diagnostics ensures early detection and prompt treatment of sepsis. Moreover, it requires healthcare professionals’ expertise to evaluate and interpret the laboratory & imaging data which results in early and accurate detection. Further, the cost-effectiveness of conventional diagnostics as compared to automated diagnostics will spur the business landscape.

Based on pathogen type, the sepsis diagnostics market is bifurcated into bacterial sepsis, fungal sepsis, and others. Bacterial sepsis is leading the market due to an increase in bacterial sepsis patients and a rise in surgical operations. Furthermore, the increased occurrence of hospital-acquired infections in individuals that are already suffering from ill ailments leads to bacterial sepsis.

Based on end-use, the sepsis diagnostics market is divided into hospitals, diagnostic centres, clinics, and others. Hospitals held a significant revenue around 300 million and is estimated to grow approximately 618 million by 2032. The high frequency of sepsis, along with a large number of fatalities caused by disease and an increasing number of patients owing to improved awareness, will result in hospitals dominating the sepsis diagnostics industry. Furthermore, improved research and diagnosis in hospital laboratories, as well as increased disposable income in developed nations, will significantly contribute to the use of sepsis diagnostics in hospitals, resulting in segment expansion.

The presence of highly developed healthcare systems and the implementation of innovative sepsis diagnostic technologies has enhanced the need for sepsis diagnostics in North America. Furthermore, rising instances of healthcare-associated infections as a result of an increasing number of surgical operations and technological improvements, notably in North America, will drive the potential for market outlook in the coming years.